Definitive Healthcare Corp. - Common Stock (DH) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
DH on Nasdaq
Shares outstanding
115,412,767
Price per share
$2.87
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
95,534,543
Total reported value
$387,822,392
% of total 13F portfolios
0%
Share change
-2,476,564
Value change
-$9,933,596
Number of holders
127
Price from insider filings
$2.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Definitive Healthcare Corp. - Common Stock (DH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADVENT INTERNATIONAL, L.P. 55% $163,069,593 58,869,889 ADVENT INTERNATIONAL, L.P. 31 Mar 2025
Krantz Jason Ronald 17% $61,381,713 22,159,463 Jason Ronald Krantz 31 Mar 2025
GOLDMAN SACHS GROUP INC 7.7% $24,131,952 8,711,896 THE GOLDMAN SACHS GROUP, INC. 31 Mar 2025
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 4.3% $13,746,815 4,962,749 Massachusetts Financial Services Company 31 Dec 2024

As of 30 Sep 2025, 127 institutional investors reported holding 95,534,543 shares of Definitive Healthcare Corp. - Common Stock (DH). This represents 83% of the company’s total 115,412,767 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Definitive Healthcare Corp. - Common Stock (DH) together control 80% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Advent International, L.P. 54% 62,493,676 0% 5.1% $253,724,324
GOLDMAN SACHS GROUP INC 6.3% 7,309,792 -16% 0% $29,677,756
BlackRock, Inc. 2.7% 3,123,380 +0.25% 0% $12,680,922
VANGUARD GROUP INC 2.4% 2,770,782 -5.3% 0% $11,249,375
PALISADE CAPITAL MANAGEMENT, LP 1.9% 2,142,782 -1.8% 0.24% $8,699,695
DIMENSIONAL FUND ADVISORS LP 1.8% 2,073,197 +1.6% 0% $8,417,016
D. E. Shaw & Co., Inc. 1.6% 1,803,959 +28% 0.01% $7,324,074
MORGAN STANLEY 1.2% 1,399,794 -9.8% 0% $5,683,164
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 1,216,007 +12% 0% $4,936,988
STATE STREET CORP 1% 1,172,713 -1.3% 0% $4,761,215
GEODE CAPITAL MANAGEMENT, LLC 0.92% 1,057,647 -6.4% 0% $4,295,529
NEW YORK STATE COMMON RETIREMENT FUND 0.66% 766,433 0% 0% $3,111,718
RENAISSANCE TECHNOLOGIES LLC 0.58% 670,240 -4.7% 0% $2,721,174
AQR CAPITAL MANAGEMENT LLC 0.51% 593,382 -11% 0% $2,409,131
NORTHERN TRUST CORP 0.43% 490,867 +42% 0% $1,992,920
Corient Private Wealth LLC 0.39% 450,017 0% $1,827,070
BANK OF AMERICA CORP /DE/ 0.36% 410,878 -47% 0% $1,668,165
UBS Group AG 0.33% 376,909 -21% 0% $1,530,251
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.32% 374,531 -6.9% 0% $1,520,596
JANE STREET GROUP, LLC 0.28% 323,792 -1.4% 0% $1,314,596
CITIGROUP INC 0.25% 289,087 +123% 0% $1,173,693
Connor, Clark & Lunn Investment Management Ltd. 0.22% 255,240 -29% 0% $1,036,274
CLARK ESTATES INC/NY 0.21% 239,630 0% 0.22% $972,898
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.19% 215,000 0% 0.01% $872,900
Bank of New York Mellon Corp 0.17% 200,511 +2.6% 0% $814,074

Institutional Holders of Definitive Healthcare Corp. - Common Stock (DH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 134,406 $382,141 +$10,848 $2.87 6
2025 Q3 95,534,543 $387,822,392 -$9,933,596 $4.06 127
2025 Q2 97,972,684 $382,095,091 -$10,879,378 $3.90 120
2025 Q1 102,223,415 $295,430,701 -$19,223,412 $2.89 135
2024 Q4 105,002,680 $431,561,963 -$4,204,709 $4.11 127
2024 Q3 105,482,311 $471,507,498 -$38,682,283 $4.47 123
2024 Q2 112,234,896 $612,700,742 -$45,797,075 $5.46 141
2024 Q1 114,517,287 $924,031,994 -$3,597,464 $8.07 140
2023 Q4 114,820,420 $1,141,311,429 -$35,980,176 $9.94 136
2023 Q3 118,669,856 $948,162,108 +$8,152,353 $7.99 129
2023 Q2 117,350,923 $1,290,775,978 +$47,553,075 $11.00 134
2023 Q1 113,324,502 $1,170,641,715 +$50,921,386 $10.33 139
2022 Q4 108,510,002 $1,192,966,935 +$5,165,920 $10.99 131
2022 Q3 108,840,769 $1,691,286,496 +$41,279,273 $15.54 117
2022 Q2 104,223,018 $2,390,143,225 +$129,457,966 $22.93 112
2022 Q1 98,638,271 $2,431,387,918 +$31,628,129 $24.65 89
2021 Q4 96,994,684 $2,650,863,189 +$260,081,912 $27.33 89
2021 Q3 83,307,058 $3,568,038,000 +$3,568,037,991 $42.83 76